AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery-Reference-Cited by-同舟云学术

AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery

Published:2023-05 Issue: Volume:946 Page:175579
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Abdelazeem Heba,Tu Ly,Thuillet Raphaël,Ottaviani Mina,Boulfrad Achraf,Beck Thomas,Senbel Amira,Mani Salma,Castier Yves,Guyard Alice,Tran-Dinh Alexy,El-Benna Jamel,Longrois Dan,Silverstein Adam M.,Guignabert Christophe,Norel Xavier^ORCID

Funder

United Therapeutics Corporation

Publisher

Elsevier BV

Subject

Pharmacology

Reference67 articles.

1. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension;Agard;Br. J. Pharmacol.,2009

2. Emerging role of cAMP/AMPK signaling;Aslam;Cells,2022

3. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats;Bordenave;Cardiovasc. Res.,2020

4. Mechanistic phase II clinical trial of metformin in pulmonary arterial hypertension;Brittain;J. Am. Heart Assoc.,2020

5. Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis;Cathcart;J. Pharmacol. Exp. Therapeut.,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol attenuates cyclosporin A-induced upregulation of the thromboxane A2 receptor and hypertension via the AMPK/SIRT1 and MAPK/NF-κB pathways in the rat mesenteric artery;European Journal of Pharmacology;2024-06

2. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension;Biomedicine & Pharmacotherapy;2024-05

3. The role and mechanism of AMPK in pulmonary hypertension;Therapeutic Advances in Respiratory Disease;2024-01

4. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates vascular remodeling in MCT-induced pulmonary arterial hypertension;2023-12-28

5. Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease;Journal of Personalized Medicine;2023-12-20